Franklin Resources’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Franklin Resources’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-134	Closed	-$116K	–	1555
2018 Q2	$116K	Hold	134	–	–	﹤0.01%	1455
2018 Q1	$168K	Sell	134 -1,266	-90%	-$1.87M	﹤0.01%	1485
2017 Q4	$2.09M	Hold	1,400	–	–	﹤0.01%	1216
2017 Q3	$2.87M	Hold	1,400	–	–	﹤0.01%	1168
2017 Q2	$3.93M	Hold	1,400	–	–	﹤0.01%	1117
2017 Q1	$4.2M	Hold	1,400	–	–	﹤0.01%	1133
2016 Q4	$2.08M	Hold	1,400	–	–	﹤0.01%	1225
2016 Q3	$2.5M	Hold	1,400	–	–	﹤0.01%	1224
2016 Q2	$2.63M	Hold	1,400	–	–	﹤0.01%	1215
2016 Q1	$3.14M	Hold	1,400	–	–	﹤0.01%	1180
2015 Q4	$3.34M	Hold	1,400	–	–	﹤0.01%	1209
2015 Q3	$3.33M	Buy	+1,400	New	+$3.71M	﹤0.01%	1208

Other funds holding NBRV

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Franklin Resources's NBRV Position: Q3 2018 in Review

Franklin Resources sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2018, closing a stake of 134 shares — an estimated $116K sold.

Franklin Resources first reported a position in NBRV in Q3 2015 and held it in 12 quarters. The position peaked at $4.2M in Q1 2017. 45 funds tracked by Wall St. Rank hold NBRV as of Q3 2018.

Franklin Resources reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2018 after selling out during the quarter.
Franklin Resources sold 134 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2018, an estimated $116K.
Franklin Resources first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 12 quarters.
Franklin Resources's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $4.2M in Q1 2017.
45 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2018.

Based on Franklin Resources's 13F filing for Q3 2018, filed 13 Nov 2018.